Terms: = Gastric cancer AND SMARCA4, hSNF2b, 6597, P51532, BRG1, SNF2L4, SNF2, SWI2, FLJ39786, BAF190, SNF2LB, SNF2-BETA, ENSG00000127616 AND Prognosis
9 results:
1. Expression of SMARCA2 and smarca4 in gastric adenocarcinoma and construction of a nomogram prognostic model.
Zhang Z; Li Q; Sun S; Li Z; Cui Z; Liu Q; Zhang Y; Xiong S; Zhang S
Int J Clin Oncol; 2023 Nov; 28(11):1487-1500. PubMed ID: 37634210
[TBL] [Abstract] [Full Text] [Related]
2. [Clinicopathological characteristics of gastric smarca4-deficient undifferentiated/rhabdoid carcinoma].
Wu JY; Jiang K; Yan LJ; Yin LS; Huang XZ; Jia L; Sun Y
Zhonghua Bing Li Xue Za Zhi; 2023 May; 52(5):447-453. PubMed ID: 37106285
[No Abstract] [Full Text] [Related]
3. smarca4 and SMARCE1 in gastric cancer: Correlation with ARID1A, and microsatellite stability, and SMARCE1/ERBB2 co-amplification.
Pries K; Krüger S; Heckl S; Behrens HM; Röcken C
Cancer Med; 2023 May; 12(9):10423-10437. PubMed ID: 36916408
[TBL] [Abstract] [Full Text] [Related]
4. Switch/Sucrose Non-Fermentable Complex-Deficient Rhabdoid Carcinoma of Stomach: A Rare Case Report and Literature Review.
Chen M; Yao X; Ping J; Shen H; Wei Y; Wang WL
Int J Surg Pathol; 2023 Oct; 31(7):1364-1374. PubMed ID: 36895105
[TBL] [Abstract] [Full Text] [Related]
5. Impact of mature tertiary lymphoid structures on prognosis and therapeutic response of Epstein-Barr virus-associated gastric cancer patients.
Yin YX; Ling YH; Wei XL; He CY; Wang BZ; Hu CF; Lin WP; Nie RC; Chen JW; Lin JL; Zhou J; Xie JJ; Yun JP; Xie D; Xue LY; Cai MY
Front Immunol; 2022; 13():973085. PubMed ID: 36591236
[TBL] [Abstract] [Full Text] [Related]
6. Clinicopathological and prognostic significance of SWI/SNF complex subunits in undifferentiated gastric carcinoma.
Zhang Z; Li Q; Sun S; Li Z; Cui ZG; Zhang M; Liu Q; Zhang Y; Xiong S; Zhang S
World J Surg Oncol; 2022 Dec; 20(1):383. PubMed ID: 36464671
[TBL] [Abstract] [Full Text] [Related]
7. Efficacy and predictive biomarkers of immunotherapy in Epstein-Barr virus-associated gastric cancer.
Bai Y; Xie T; Wang Z; Tong S; Zhao X; Zhao F; Cai J; Wei X; Peng Z; Shen L
J Immunother Cancer; 2022 Mar; 10(3):. PubMed ID: 35241494
[TBL] [Abstract] [Full Text] [Related]
8. Tumor progression by epithelial-mesenchymal transition in ARID1A- and smarca4-aberrant solid-type poorly differentiated gastric adenocarcinoma.
Sasaki T; Kohashi K; Kawatoko S; Ihara E; Oki E; Nakamura M; Ogawa Y; Oda Y
Virchows Arch; 2022 May; 480(5):1063-1075. PubMed ID: 34997313
[TBL] [Abstract] [Full Text] [Related]
9. [gastric SWI/SNF-complex deficient undifferentiated/rhabdoid carcinoma: a clinicopathological study].
Wang L; Tan C; Ni SJ; Jiang WH; Xu J; Cai X; Huang D; Sheng WQ; Chang B
Zhonghua Bing Li Xue Za Zhi; 2021 Jun; 50(6):632-637. PubMed ID: 34078052
[No Abstract] [Full Text] [Related]
